239 results
Page 2 of 12
8-K
EX-4.1
ah3pjjc op4vnc
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-4.3
g3e3h3yv
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-10.1
ne85dh01ti61y
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-4.2
6j2e13x
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
424B5
bzrad4
21 Apr 23
Prospectus supplement for primary offering
5:14pm
424B5
6lqrq f5s1c
20 Apr 23
Prospectus supplement for primary offering
8:09am
S-8
jwup33
22 Dec 22
Registration of securities for employees
5:37pm
S-8
cpq9l76c1ydmr5
22 Dec 22
Registration of securities for employees
5:37pm
8-K
EX-10.17
b584355z 9vhob57g
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.15
fzyk8qvamyz47d0b
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.16
fbusfly
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.3
orl71dtqiu9 r817vu
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-3.3
8bd2gern
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.6
mqpntx95
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K/A
o5iydf8w03lfd3wuve
16 Dec 22
Other Events
2:58pm
425
ux377c57gf1cr3l
5 Dec 22
Business combination disclosure
9:28am
8-K
EX-10.3
cc55 saobb
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am
425
g0wryocpqwqjsm3dzbn4
27 Oct 22
Business combination disclosure
7:15am